Advertisement

Topics

Thomson Reuters Healthcare Company Profile

16:35 EDT 25th September 2017 | BioPortfolio


News Articles [2380 Associated News Articles listed on BioPortfolio]

William G. Bithoney, MD, Joins the Healthcare Business of Thomson Reuters

ANN ARBOR, Mich., Feb. 13, 2012 /PRNewswire/ -- William G. Bithoney, MD is joining the Healthcare business of Thomson Reuters as the National Provider Business Medical Leader. (Logo: http://phot...

Most Americans say Republican healthcare plan will be harmful: Reuters/Ipsos poll

NEW YORK (Reuters) - When U.S. Senate Republicans unveil their plan to overhaul America's healthcare system, they will face a skeptical public that already does not buy the justification for an earlie...

H.C. Wainwright Analysts Earn Number One Rankings in 2017 Thomson Reuters Analyst Awards

H.C. Wainwright & Co., LLC (“HCW”), the leading investment bank focused on capital markets and equity research in the Life Sciences and Biotechnology sectors, is pleased t...

Merck Q2 Profit Beats Estimates; Worldwide Sales Up 1%

KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) reported second-quarter Non-GAAP EPS of $1.01 compared to $0.93, a year ago. On average, 16 analysts polled by Thomson Reuters expected the company to repor...

Psychiatric Medication Spending Growth Slows, According to New Thomson Reuters Research

WASHINGTON, Feb. 1, 2012 /PRNewswire/ -- The national growth rate for psychiatric medication spending has declined significantly, according to a new study conducted by researchers from Thomson Re...

CTI BioPharma Corp (CTIC) Issues Earnings Results

CTI BioPharma Corp released its quarterly earnings data on Wednesday. The biopharmaceutical company reported EPS for the quarter, missing the Thomson Reuters' consensus estimate of by $0.01.

Exclusive: Majority of Americans want Congress to move on from healthcare reform - Reuters/Ipsos poll

NEW YORK (Reuters) - A majority of Americans are ready to move on from healthcare reform at this point after the U.S. Senate's effort to dismantle Obamacare failed on Friday, according to an exclusive...

Mylan (MYL) Issues Earnings Results, Beats Estimates By $0.01 EPS

Mylan posted its quarterly earnings results on Wednesday. The company reported $0.93 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.92 by $0.01.

Clinical Trials [787 Associated Clinical Trials listed on BioPortfolio]

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)

This study is designed to analyze the frequency and incidence rate of pulmonary complications in JIA participants who received biological DMARDs and non-biologic DMARDs. The participants h...

My Life, My Healthcare

This study is designed to answer the following questions: "Is the My Life, My Healthcare Discussion Aid feasible for use in primary care? Does it positively impact patient and healthcare t...

Asymptomatic Flu Project

Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very i...

Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care

Recently, we generated a new multidisciplinary ubiquitous healthcare system by upgrading our clinical decision supporting system (CDSS) rule engine, and integrating a physical activity-mon...

Implementation of Medical Weight Management by Telemedicine

As the prevalence and associated healthcare costs of obesity continue to increase, the need for obesity treatments that contribute to weight loss maintenance are needed. Through the functi...

Companies [1765 Associated Companies listed on BioPortfolio]

Thomson Reuters Foundation

Established in 1982, Thomson Reuters Foundation is a registered charity in Britain and the United States. The charitable arm of Thomson Reuters, it leverages the skills and expertise across the co...

Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to ...

Thomson Reuters IP Solutions

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to ...

The Scientific business of Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information...

The Tax & Accounting business of Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to l...

More Information about "Thomson Reuters Healthcare" on BioPortfolio

We have published hundreds of Thomson Reuters Healthcare news stories on BioPortfolio along with dozens of Thomson Reuters Healthcare Clinical Trials and PubMed Articles about Thomson Reuters Healthcare for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Thomson Reuters Healthcare Companies in our database. You can also find out about relevant Thomson Reuters Healthcare Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record